1[1]Chang AE,Johnson TM,Rees R.Cutaneous neoplasms.In:Greenfield LJ,Mulholl and MW,Oldham KT,editors.Surgery:scientific principles and practice [J].Philadelphia:Lippincott￣Raven,1997,2231-46.
2[2]Santinarni M,Maurici A,Patuzzo R,et al.Impact of clinical trials on the treatment of melanoma [J].Surg Oncol Clin N Am,2001,10:935-47.[3] Balch CM,Soong SJ,Ross MI,et al.Long￣term results of a prospective surgical trial comparing 2 cm vs.4 cm excision margins for 740 patients with 1-4 mm melanomas [J].Ann Surg Oncol,2001,8:101-8.
3[3]Heaton KM,Sussman JJ,Gershenwald JE,et al .Surgical margins and prognostic factors in patients with thick(＞4 mm) primary melanoma[J].Ann Surg Oncol,1998,5:322-8.
4[4]Balch CM,Cascinelli N,Milton GW.Elective node dissection:pros and cons.In:Balch CM,Milton GW,editors.Cutaneous melanoma:clinical management and treatment results world wide [J].Philadelphia:J.B.Lippincott,1985,131.
5[5]Balch C,Buzaid AC,Atkins MB,et al.A nes Wmerican joint committee on cancer staging system for cutaneous melanoma [J].Cancer,2000,88:1481-91.
6[6]Gershenwald JE,Thompson W,Mansfield PF,Lee J.Multiinstitutional Melanoma lymphatic mapping experience:the prognostic value of sentinel lymph node status in 612 stage Ⅰ or Ⅱ melanoma patients [J].J Clin Oncol,1999,17:976-83.
7[7]Cascinelli N,Belli F,Santinarni M.Sentinel lymph node biopsyin cutaneous melanoma:the WHO melanoma program experience [J].Ann Surg Oncol,2000,7:469-74.
8[8]Morton D,Thompson JF,Essner R,et al.Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early￣stage melanoma:a multicenter trial.Multicenter Selective Lymphadenectomy Trial Group [J].Ann Surg,1999,230:453-65.
9[9]Gershenwald JE,Thompson W,Mansfield PF,Lee J.Multiinstitutional melanoma lymphatic mapping experience:the prognostic value of sentinel lymph node status in 612 stage Ⅰ or Ⅱ melanoma patients [J].J Clin Oncol,1999,17:976-83.
10[10]Kirkwood J,Strawderman M,Ernstoff M,et al.Interferonalpha￣2b adjuvant therapy of high￣risk resected cutaneous melanoma;the Eastern Cooperative Oncology Group Trial EST 1684 [J].J Clin Oncol,1996,14:7-17.
3Stattin P,Bjor O,Ferrari P,et al.Prospective Study of Hyperglycemia and Cancer Risk[J].Diabetes Care,2007,30(3):561-567.
4Apelqvist J,Bakker K,van Houtum W H,et al.International consensus and practical guidelines on the management and the prevention of the diabetic foot.International Working Group on the Diabetic Foot[J].Diabetes Metab Res Rev,2000,16(suppl 1):84-92.
